Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study
Miller, T.P.; Jones, S.E.; Rainey, J.M.
Cancer Treatment Reports 67(7-8): 739-740
1983
ISSN/ISBN: 0361-5960 PMID: 6688200 Document Number: 219115
Document emailed within 1 workday
Related Documents
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688
Curry, S.L.; Blessing, J.A.; Disaia, P.J.; Soper, J.T.; Twiggs, L.B. 1989: A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study Obstetrics and Gynecology 73(3 Pt 1): 357-362
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Cowan, J.D.; Surwit, E.A.; Alberts, D.S.; Boutselis, J.G.; Neilan, B.A. 1986: Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study Cancer Treatment Reports 70(3): 423-424
Weiss, G.B.; Metch, B.; Von Hoff, D.D.; Taylor, S.A.; Saiers, J.H. 1987: Phase Ii trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1313-1314
Bezwoda, W.R.; Rastogi, R.B. 1994: A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up Seminars in Hematology 31(2 Suppl 3: 3
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Coltman, C.A.; Dixon, D.O. 1982: Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup Cancer Treatment Reports 66(4): 1023-1033
Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22
Van Eys, J.; Chen, T.; Moore, T.; Cheek, W.; Sexauer, C.; Starling, K. 1981: Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study Cancer Treatment Reports 65(7-8): 681-684
Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Nitschke, R.; Starling, K.; Lui, V.K.; Pullen, J. 1981: Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: a Southwest Oncology Group Study Cancer Treatment Reports 65(11-12): 1105-1108
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Goodwin, W.; Stephens, R.; McCracken, J.D.; Groppe, C. 1981: Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study Cancer Treatment Reports 65(3-4): 359
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Saiki, J.H.; Baker, L.H.; Stephens, R.L.; Fabian, C.J.; Kraut, E.H.; Fletcher, W.S. 1982: Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study Cancer Treatment Reports 66(8): 1673-1674